Ji Hye Jo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ji Hye Jo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- In Yang Park
Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications - Hyun Sun Ko
Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 shared publications - Bo Yun Choi
Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
1 shared publication - Geum Joon Cho
Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
1 shared publication Guk Won Kim
The Catholic University of Korea
1 shared publication- Heesu Yoon
Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
1 shared publication
Latest Publications
- Open Access
- 20 January 2023
- Published by Springer Nature in Research Square
A multicenter, retrospective comparison of pregnancy outcomes according to placental location in placenta previa
Purpose To evaluate pregnancy outcomes according to placental location in women with placenta previa and to evaluate the risk of adverse outcomes in women with anterior placenta previa. Methods This retrospective cohort study was conducted on cesarean deliveries due to placenta previa at three university hospitals between May 1999 and February 2020. Patients were categorized into anterior previa (209 women) and posterior previa (572 women) groups. We analyzed the demographic factors, obstetric outcomes, and neonatal outcomes of the two groups. Results High maternal parity was associated with a greater occurrence of anterior placenta previa. More pregnant women in the anterior group were hospitalized because of vaginal bleeding during pregnancy. A high percentage of patients in the anterior group had undergone a previous cesarean section. Blood transfusion is more common among patients with anterior placenta previa thanthose with posterior placenta previa;anterior placenta previa is more likely to accompany placenta accreta spectrum. In the anterior group, more cases were born with an abnormal fetal presentation. Conclusion Anterior previa is more common in higher parity and is more fatal than posterior previa because of increased maternal morbidity such as excessive blood loss, massive transfusion, and placental accreta. It is important to accurately determine the location of the placenta using ultrasound during antenatal care visits. A multidisciplinary approach becomes relevant in the case of anterior PP because of the risk of bleeding that necessitates blood transfusion.
- 20 January 2023
- Published by Springer Nature in Research Square
Open AccessA multicenter, retrospective comparison of pregnancy outcomes according to placental location in placenta previa
Purpose To evaluate pregnancy outcomes according to placental location in women with placenta previa and to evaluate the risk of adverse outcomes in women with anterior placenta previa. Methods This retrospective cohort study was conducted on cesarean deliveries due to placenta previa at three university hospitals between May 1999 and February 2020. Patients were categorized into anterior previa (209 women) and posterior previa (572 women) groups. We analyzed the demographic factors, obstetric outcomes, and neonatal outcomes of the two groups. Results High maternal parity was associated with a greater occurrence of anterior placenta previa. More pregnant women in the anterior group were hospitalized because of vaginal bleeding during pregnancy. A high percentage of patients in the anterior group had undergone a previous cesarean section. Blood transfusion is more common among patients with anterior placenta previa thanthose with posterior placenta previa;anterior placenta previa is more likely to accompany placenta accreta spectrum. In the anterior group, more cases were born with an abnormal fetal presentation. Conclusion Anterior previa is more common in higher parity and is more fatal than posterior previa because of increased maternal morbidity such as excessive blood loss, massive transfusion, and placental accreta. It is important to accurately determine the location of the placenta using ultrasound during antenatal care visits. A multidisciplinary approach becomes relevant in the case of anterior PP because of the risk of bleeding that necessitates blood transfusion.
- Open Access
- 28 September 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (19) , 5733
COVID-19 Vaccine Acceptance during Pregnancy and Influencing Factors in South Korea
Pregnant women were excluded from vaccination against Coronavirus 2019 (COVID-19) until September 2021 in South Korea. Although vaccination for pregnant women started in October 2021, vaccine acceptance in pregnant women is yet unknown. This cross-sectional study aimed to investigate COVID-19 vaccine acceptance during pregnancy and influencing factors. An anonymous survey was distributed in obstetrics departments to all pregnant or postpartum women, during the prenatal or postpartum visit. The proportion of self-reported COVID-19 vaccination during pregnancy among 436 women was 26.6%. Pregnancy-related independent factors influencing maternal COVID-19 vaccination were “received vaccine information about from obstetrics and gynecology (OBGYN) doctors” (OR 3.41, 95% CI 2.05–5.65), “cohabitant COVID-19 vaccination” (OR 2.43, 95% CI 1.06–5.59), and “second trimester” (OR 7.35, 95% CI 1.54–35.15). In women who did not want to get vaccinated, the most common reason for COVID-19 vaccination hesitancy was concern that COVID-19 vaccine might affect the fetus (91.7%, 243/266), followed by distrust in COVID-19 vaccine effectiveness (42.6%, 113/266). This study showed that providing information about maternal COVID-19 vaccination, especially by OBGYN doctors, is crucial for increasing vaccination coverage in pregnant women. Providing updated evidence of COVID-19 vaccine efficacy and safety in pregnant women may be also helpful for increasing vaccine acceptance.
- 28 September 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (19) , 5733
Open AccessCOVID-19 Vaccine Acceptance during Pregnancy and Influencing Factors in South Korea
Pregnant women were excluded from vaccination against Coronavirus 2019 (COVID-19) until September 2021 in South Korea. Although vaccination for pregnant women started in October 2021, vaccine acceptance in pregnant women is yet unknown. This cross-sectional study aimed to investigate COVID-19 vaccine acceptance during pregnancy and influencing factors. An anonymous survey was distributed in obstetrics departments to all pregnant or postpartum women, during the prenatal or postpartum visit. The proportion of self-reported COVID-19 vaccination during pregnancy among 436 women was 26.6%. Pregnancy-related independent factors influencing maternal COVID-19 vaccination were “received vaccine information about from obstetrics and gynecology (OBGYN) doctors” (OR 3.41, 95% CI 2.05–5.65), “cohabitant COVID-19 vaccination” (OR 2.43, 95% CI 1.06–5.59), and “second trimester” (OR 7.35, 95% CI 1.54–35.15). In women who did not want to get vaccinated, the most common reason for COVID-19 vaccination hesitancy was concern that COVID-19 vaccine might affect the fetus (91.7%, 243/266), followed by distrust in COVID-19 vaccine effectiveness (42.6%, 113/266). This study showed that providing information about maternal COVID-19 vaccination, especially by OBGYN doctors, is crucial for increasing vaccination coverage in pregnant women. Providing updated evidence of COVID-19 vaccine efficacy and safety in pregnant women may be also helpful for increasing vaccine acceptance.
- Open Access
- 3 May 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-7
The trend in cesarean myomectomies and the risk of obstetrical complications in Korea
To evaluate pregnancy outcomes and the risk of adverse obstetrical outcomes of cesarean myomectomy (CM) compared with cesarean section (CS) only, and to investigate the trend of surgeons in choosing CM. A retrospective cohort study was performed on all patients who underwent CS complicated by leiomyoma at two university hospitals between January 2010 and May 2020. All patients were categorized into the CM (341 women) or CS-only (438 women) group. We analyzed the demographic factors, obstetric factors, surgical outcomes, and possible risk factors for adverse outcomes between the two groups. Women who underwent CS only were significantly more likely to have a previous myomectomy and multiple leiomyoma history than women who underwent CM. The gestational age at delivery and pregnancy complications were significantly higher in the CS-only group. The mean size of the leiomyomas was larger in the CM group than in the CS-only group (5.8 ± 3.2 cm vs. 5.2 ± 3.1 cm, P = 0.005). The operation time and history of previous CS and preterm labor were higher in the CM group. The leiomyoma types differed between the two groups. The subserosal type was the most common in the CM group (48.7%), and the intramural type was the most common in the CS-only group. Patients in the CM group had fewer than three leiomyomas than those in the CS-only group. Preterm labor and abnormal presentation were relatively higher in the CM group than in the CS-only group, concerning leiomyoma presence. There were no significant differences in the preoperative and postoperative hemoglobin levels. The size of the leiomyoma (odds ratio [OR] = 1.162; 95% confidence interval [CI]: 1.07–1.25; P < 0.001) and operation time > 60 min (OR = 2.461; 95% CI: 1.45–4.15) were significant independent predictors of adverse outcomes after CM. CM should be considered a reliable and safe approach to prevent the need for another surgery for remnant leiomyoma. Herein, surgeons performed CM when uterine leiomyomas were large, of the subserosal type, or few. Standardized treatment guidelines for myomectomy during CSs in pregnant women with uterine fibroids should be established.
- 3 May 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-7
Open AccessThe trend in cesarean myomectomies and the risk of obstetrical complications in Korea
To evaluate pregnancy outcomes and the risk of adverse obstetrical outcomes of cesarean myomectomy (CM) compared with cesarean section (CS) only, and to investigate the trend of surgeons in choosing CM. A retrospective cohort study was performed on all patients who underwent CS complicated by leiomyoma at two university hospitals between January 2010 and May 2020. All patients were categorized into the CM (341 women) or CS-only (438 women) group. We analyzed the demographic factors, obstetric factors, surgical outcomes, and possible risk factors for adverse outcomes between the two groups. Women who underwent CS only were significantly more likely to have a previous myomectomy and multiple leiomyoma history than women who underwent CM. The gestational age at delivery and pregnancy complications were significantly higher in the CS-only group. The mean size of the leiomyomas was larger in the CM group than in the CS-only group (5.8 ± 3.2 cm vs. 5.2 ± 3.1 cm, P = 0.005). The operation time and history of previous CS and preterm labor were higher in the CM group. The leiomyoma types differed between the two groups. The subserosal type was the most common in the CM group (48.7%), and the intramural type was the most common in the CS-only group. Patients in the CM group had fewer than three leiomyomas than those in the CS-only group. Preterm labor and abnormal presentation were relatively higher in the CM group than in the CS-only group, concerning leiomyoma presence. There were no significant differences in the preoperative and postoperative hemoglobin levels. The size of the leiomyoma (odds ratio [OR] = 1.162; 95% confidence interval [CI]: 1.07–1.25; P < 0.001) and operation time > 60 min (OR = 2.461; 95% CI: 1.45–4.15) were significant independent predictors of adverse outcomes after CM. CM should be considered a reliable and safe approach to prevent the need for another surgery for remnant leiomyoma. Herein, surgeons performed CM when uterine leiomyomas were large, of the subserosal type, or few. Standardized treatment guidelines for myomectomy during CSs in pregnant women with uterine fibroids should be established.
- Open Access
- 1 January 2022
- Published by XMLink in Perinatology
- Vol. 33 (2) , 96-101
Don’t Hesitate on Performing Laparoscopic Surgery for Ovarian Masses during Pregnancy: A Multidisciplinary Approach to Ovarian Masses Complicating Pregnancy
Oh S, et al. Perinatology. 2022 Jun;33(2):96-101. https://doi.org/10.14734/PN.2022.33.2.96
- 1 January 2022
- Published by XMLink in Perinatology
- Vol. 33 (2) , 96-101
Open AccessDon’t Hesitate on Performing Laparoscopic Surgery for Ovarian Masses during Pregnancy: A Multidisciplinary Approach to Ovarian Masses Complicating Pregnancy
Oh S, et al. Perinatology. 2022 Jun;33(2):96-101. https://doi.org/10.14734/PN.2022.33.2.96